Effects and safety profile of commonly used herbal anti-diabetic preparations

Suhani Sinha; Soubhik Khatua

doi:10.30574/gscbps.2018.4.2.0067

Authors

Suhani Sinha Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Sohna Road, Gurgaon, Haryana, India.
Soubhik Khatua Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Sohna Road, Gurgaon, Haryana, India.

DOI:

https://doi.org/10.30574/gscbps.2018.4.2.0067

Keywords:

Anti-diabetic, Ayurvedic herbs, Ayurvedic preparations, Safety, Medicinal plants

Abstract

Since ancient times, plants have been helping human beings to treat various ailments. Several medicinal plants are commonly being used in the management of diabetes particularly in the developing countries where resources are insufficient. Diabetes mellitus is metabolic disorders which has become very common with almost about 2.8% of the morbidity worldwide. In the present review, a special emphasis is given on some commonly used Ayurvedic medicinal plants having hypoglycemic properties and their anti-diabetic preparations. The review presents information regarding the scientific name (genus-species), family, preparation used, the evidence of hypoglycemic activity, the active agents and safety profile. This review could be useful to researchers, clinicians, pharmacists as well as common man from the society as a basic information for further development of anti-diabetic herbal remedies.

Metrics

Metrics Loading ...

References

Tiwari AK and Rao JM. (2002). Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Current science, 30-38.

Ekor M and Ekor M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in pharmacology, 4, 177.

Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A and Devasagayam T. (2007). Indian herbs and herbal drugs used for the treatment of diabetes. Journal of Clinical Biochemistry and Nutrition, 40(3), 163-173.

Rajput DS, Dash DK, Sahu AK, Mishra K, Kashyap P and Mishra SP. (2017). Brief update on Indian herbs and spices used for diabetes in rural area of Chhattisgarh. International Journal of Pharmaceutical Chemistry and Analysis, 4(1), 1-4.

Ingole RK. (2013). Antidiabetic drugs in Ayurveda. International Research Journal of Pharmacy, 4(6), 21-24.

Tyler VE. (2000. Herbal medicine: from the past to the future. Public Health Nutrition, 3(4a), 447-52.

Junaid AB and Nasreen R. (2012). Regulatory aspects of traditional medicine: focus towards Unani cosmeceutical products. International Journal of Pharmaceutical Sciences and Research, 3(6), 1768.

Nasri H, Shirzad H, Baradaran A and Rafieian-Kopaei M. (2015). Antioxidant plants and diabetes mellitus. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 20(5), 491.

Sengkhamparn N, Verhoef R, Schols HA, Sajjaanantakul T and Voragen AG. (2009). Characterisation of cell wall polysaccharides from okra (Abelmoschus esculentus (L.) Moench). Carbohydrate Research, 344(14), 1824-32.

Khatun H, Rahman A, Biswas M and Islam AU. (2011). Water-soluble fraction of Abelmoschus esculentus L Interacts with glucose and metformin hydrochloride and alters their absorption kinetics after co-administration in rats. ISRN pharmaceutics.

Gemede HF, Ratta N, Haki GD, Woldegiorgis AZ and Bey F. (2014). Nutritional quality and health benefits of okra (Abelmoschus esculentus): a review. Global Journal of Medical Research.

Fan S, Zhang Y, Sun Q, Yu L, Li M, Zheng B, Wu X, Yang B, Li Y and Huang C. (2014). Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice. The Journal of nutritional biochemistry, 25(7), 702-9.

Okpala B. (2015). Benifits of Okra (Ladies Fingers), 11/8/2015. [Online]. Available: https://globalfoodbook.com/benefits-of-okra-ladies-fingers. [Accessed 4 August 2018].

Kumar J and Kumar M. (2011). Medicinal plants for diabetes mellitus: A traditional approach. International Archive of Applied Sciences and Technology, 2(1), 37 -46.

Sabitha V, Ramachandran S, Naveen KR and Panneerselvam K. (2011). Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench in streptozotocin-induced diabetic rats. Journal of pharmacy and bioallied sciences, 3(3), 397.

Teshika JD, Zakariyyah AM, Toorabally Z, Zengin G, Rengasamy KR, Pandian SK and Mahomoodally FM. (2018). Traditional and modern uses of onion bulb (Allium cepa L.): A systematic review. Critical reviews in food science and nutrition, 1-75.

Upadhyay RK. (2016). Nutraceutical, pharmaceutical and therapeutic uses of Allium cepa: A review. International Journal of Green Pharmacy (IJGP), 10(1).

Akash MS, Rehman K and Chen S. (2014). Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus. Nutrition, 30(10), 1128-37.

Kumari K, Mathew BC and Augusti KT. (1995). Antidiabetic and hypolipidemic effects of S-methyl cysteine sulfoxide isolated from Allium cepa Linn. Indian Journal of Biochemistry and Biophysics, 32(1), 49-54.

Jevas C. (2011). Anti-diabetic effects of Allium cepa (onions) aqueous extracts on alloxan-induced diabetic Rattus novergicus. Journal of Medicinal Plants Research, 5(7), 1134-9.

Roldán-Marín E, Krath BN, Poulsen M, Binderup ML, Nielsen TH, Hansen M, Barri T, Langkilde S, Cano MP, Sánchez-Moreno C and Dragsted LO. (2009). Effects of an onion by-product on bioactivity and safety markers in healthy rats. British journal of nutrition, 102(11), 1574-82.

Tamayo C and Diamond S. (2007). Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). Integrative Cancer Therapies, 6(2), 146-57.

Pepping J. (1999). Milk thistle: Silybum marianum. American Journal of Health-System Pharmacy, 56(12), 1195-7.

Kazazis CE, Evangelopoulos AA, Kollas A and Vallianou NG. (2014). The therapeutic potential of milk thistle in diabetes. The review of diabetic studies: RDS, 11(2), 167.

Ramesh B, Karuna R, Reddy SS, Sudhakara G and Saralakumari D. (2013). Ethanolic extract of Commiphora mukul gum resin attenuates streptozotocin-induced alterations in carbohydrate and lipid metabolism in rats. EXCLI Journal, 12, 556.

Ghritlahare SK, Satapathy T, Panda PK and Mishra G. (2017). Ethnopharmacological story of guggulsterones: An overview. Research Journal of Pharmacognosy and Phytochemistry, 9(3), 182-8.

Shah R, Gulati V and Palombo EA. (2012). Pharmacological properties of guggulsterones, the major active components of gum guggul. Phytotherapy Research, 26(11), 1594-605.

Deng R. (2007). Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovascular drug reviews, 25(4), 375-90.

Baljinder S, Seena G, Dharmendra K, Vikas G and Bansal P. (2010). Pharmacological potential of Eriobotrya japonica-an overview. International Research Journal of Pharmacy, 1, 95-9.

Chen J, Li WL, Wu JL, Ren BR and Zhang HQ. (2008). Hypoglycemic effects of a sesquiterpene glycoside isolated from leaves of loquat (Eriobotrya japonica (Thunb) Lindl). Phytomedicine, 5(1-2), 98-102.

Said O, Saad B, Fulder S, Amin R, Kassis E and Khalil K. (2009. Hypolipidemic activity of extracts from Eriobotrya japonica and Olea europaea, traditionally used in the Greco-Arab medicine in maintaining healthy fat levels in the blood. The Open Complementary Medicine Journal, 1(1).

Miura T, Takagi S and Ishida T. (2012). Management of diabetes and its complications with banaba (Lagerstroemia speciosa L.) and corosolic acid. Evidence-Based Complementary and Alternative Medicine.

Hou W, Li Y, Zhang Q, Wei X, Peng A, Chen L and Wei Y. (2009). Triterpene acids isolated from Lagerstroemia speciosa leaves as α‐glucosidase inhibitors. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 23(5), 614-8.

Bai N, He KA, Roller M, Zheng B, Chen X, Shao Z, Peng T and Zheng Q. (2008). Active compounds from Lagerstroemia speciosa, insulin-like glucose uptake-stimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. Journal of agricultural and food chemistry, 56(24), 11668-74.

Stohs SJ, Miller H and Kaats GR. (2012). A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phytotherapy Research, 26(3), 317-24.

Bandara T, Uluwaduge I and Jansz ER. (2012). Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review. International Journal of Food Sciences and Nutrition, 63(3), 380-6.

Davis PA and Yokoyama W. (2011). Cinnamon intake lowers fasting blood glucose: meta-analysis. Journal of Medicinal Food, 14(9), 884-9.

Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E and Koren G. (2007). From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Canadian Journal of Physiology and Pharmacology, 85(9), 837-47.

Sangal A. (2011). Role of cinnamon as beneficial antidiabetic food adjunct: a review. Advances in Applied Science Research, 2(4), 440-50.

Farombi EO, Akanni OO and Emerole GO. (2002). Antioxidant and scavenging activities of flavonoid extract (kolaviron) of Garcinia kola seeds. Pharmaceutical Biology, 40(2), 107-16.

Iwu MM, Igboko OA, Okunji CO and Tempesta MS. (1990). Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. Journal of Pharmacy and Pharmacology, 42(4), 290-2.

Adaramoye OA and Adeyemi EO. (2006). Hypoglycaemic and hypolipidaemic effects of fractions from kolaviron, a biflavonoid complex from Garcinia Kola in streptozotocin‐induced diabetes mellitus rats. Journal of Pharmacy and Pharmacology, 58(1), 121-8.

Atsukwei D, Daniel EE, Odeh OS, Adams DM, Malgwi SI and Olih CP. (2015). Efficacy of Garcinia kola seed ethanolic extract on haematological parameters in male Wistar rats. Journal of Advances in Medical and Pharmaceutical Sciences, 3(1), 10-23.

Ekene EN. (2014). Garcinia kola: a review of its ethnomedicinal, chemical and pharmacological properties. International Journal of Current Research and Review. 6(11), 1.

Sharangi AB. (2009). Medicinal and therapeutic potentialities of tea (Camellia sinensis L.)–A review. Food Research International, 42(5-6), 529-35.

Namita P, Mukesh R and Vijay KJ. (2012). Camellia sinensis (green tea): A review. Global journal of pharmacology, 6(2), 52-9.

Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI and Dog TL. (2008). Safety of green tea extracts. Drug safety, 31(6), 469-84.

Rao KV. (1993). A review on Licorice. Ancient science of life, 13(1-2), 57.

Icer MA and Sanlier N. (2017). A review: Pharmacological effects of Licorice (Glycyrrhiza glabra) on human health. International Journal of Basic and Clinical Studies, 6(1), 12-26.

Fuhr L, Rousseau M, Plauth A, Schroeder FC and Sauer S. (2015). Amorfrutins are natural PPARγ agonists with potent anti-inflammatory properties. Journal of natural products, 78(5), 1160-4.

Isbrucker RA and Burdock GA. (2006). Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regulatory Toxicology and Pharmacology, 46(3), 167-92.

Pothuraju R, Sharma RK, Chagalamarri J, Jangra S and Kumar KP. (2014). A systematic review of Gymnema sylvestre in obesity and diabetes management. Journal of the Science of Food and Agriculture, 94(5), 834-40.

Tiwari P, Mishra BN and Sangwan NS. (2014). Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant. BioMed Research International.

Tiwari P, Ahmad K and Hassan Baig M. (2017). Gymnema sylvestre for diabetes: from traditional herb to future’s therapeutic. Current pharmaceutical design, 23(11), 1667-76.

Shanmugasundaram E, Gopinath K, Shanmugasundaram K and Rajendran V. (1990). Possible regeneration of the islets of langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. Journal of Ethnopharmacology, 30, 265–279.

Chattopadhyay RR. (1999). A comparative evaluation of some blood sugar lowering agents of plant origin. Journal of Ethnopharmacology, 67, 367- 372.

Grover JK and Yadav SP. (2004). Pharmacological actions and potential uses of Momordica charantia: a review. Journal of Ethnopharmacology, 93(1), 123-32.

Raman A and Lau C. (1996). Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2(4), 349-62.

Keller AC, Ma J, Kavalier A, He K, Brillantes AM and Kennelly EJ. (2011). Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine, 19(1), 32-7.

Kumar KS and Bhowmik D. (2010). Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn. International Journal of Pharmaceutical Sciences Review and Research, 4(3), 23-8.

Basch E, Gabardi S and Ulbricht C. (2003). Bitter melon (Momordica charantia): a review of efficacy and safety. American Journal of Health-System Pharmacy, 60(4), 356-9.

De Medina FS, Gamez MJ, Jimenez I, Jimenez J, Osuna JI and Zarzuelo A. (1994). Hypoglycemic activity of juniper “berries”. Planta Medica, 60(03), 197-200.

Ramachandran S, Asokkumar K, Uma Maheswari M, Ravi TK, Sivashanmugam AT, Saravanan S, Rajasekaran A and Dharman J. (2011). Investigation of antidiabetic, antihyperlipidemic, and in vivo antioxidant properties of Sphaeranthus indicus Linn. in type 1 diabetic rats: An identification of possible biomarkers. Evidence-Based Complementary and Alternative Medicine.

Andersen FA. (2001). Final report on the safety assessment of Juniperus communis extract, Juniperus oxycedrus extract, Juniperus oxycedrus tar, Juniperus phoenicea extract, and Juniperus virginiana extract. International Journal of Toxicology, 20, 41-56.

Dhanabal SP, Kokate CK, Ramanathan M, Kumar EP and Suresh B. (2006). Hypoglycaemic activity of Pterocarpus marsupium Roxb. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 20(1), 4-8.

Manickam M, Ramanathan M, Farboodniay Jahromi MA, Chansouria JP and Ray AB. Antihyperglycemic activity of phenolics from Pterocarpus marsupium. Journal of Natural Products, 60(6), 609-10.

Sheehan EW, Zemaitis MA, Slatkin DJ and Schiff Jr PL. (1983). A constituent of Pterocarpus marsupium, (-)-epicatechin, as a potential antidiabetic agent. Journal of Natural Products, 46(2), 232-4.

Lodha R and Bagga A. (2000). Traditional Indian systems of medicine. Annals of the Academy of Medicine, Singapore, 29(1), 37-41.

Haq I. (2004). Safety of medicinal plants. Pakistan Journal of Medicinal Research, 43(4), 203-10.

Mathela CS, Padalia RC and Chanotiya CS. (2009). Kanokonyl acetate-rich Indian valerian from northwestern Himalaya. Natural product communications, 4(9), 1253-6.

McClung JH. (2003). Composition for topical application to skin. United States patent US 6,579,543.

Devi VS and Rao MG. (2014). Valeriana wallichii-A rich aroma root plant. World Journal of Pharmacy and Pharmaceutical Sciences, 3, 1516-25.

Taibi DM, Landis CA, Petry H and Vitiello MV. (2007). A systematic review of valerian as a sleep aid: safe but not effective. Sleep Medicine Reviews, 11(3), 209-30.

Applequist WL and Moerman DE. (2011). Yarrow (Achillea millefolium L.): a neglected panacea? A review of ethnobotany, bioactivity, and biomedical research. Economic Botany, 65(2), 209.

Mustafa KG, Ganai BA, Akbar S, Dar MY and Masood A. (2012). β-cell protective efficacy, hypoglycemic and hypolipidemic effects of extracts of Achillea millifolium in diabetic rats. Chinese journal of natural medicines, 10(3), 185-9.

Chávez-Silva F, Cerón-Romero L, Arias-Durán L, Navarrete-Vázquez G, Almanza-Pérez J, Román-Ramos R, Ramírez-Ávila G, Perea-Arango I, Villalobos-Molina R and Estrada-Soto S. (2018). Antidiabetic effect of Achillea millefollium through multitarget interactions: α-glucosidases inhibition, insulin sensitization and insulin secretagogue activities. Journal of Ethnopharmacology, 212, 1-7.

Cavalcanti AM, Baggio CH, Freitas CS, Rieck L, De Sousa RS, Da Silva-Santos JE, Mesia-Vela S and Marques MC. (2006). Safety and antiulcer efficacy studies of Achillea millefolium L. after chronic treatment in Wistar rats. Journal of Ethnopharmacology, 107(2), 277-84.

Andersen FA. (2001). Final report on the safety assessment of Yarrow (Achillea Millefolium) extract. International Journal of Toxicology, 20, 79-84.

Otunola GA and Afolayan AJ. (2015). Antidiabetic effect of combined spices of Allium sativum, Zingiber officinale and Capsicum frutescens in alloxan-induced diabetic rats. Frontiers in Life Science, 8(4), 314-23.

Vera-Portocarrero L and Westlund KN. (2005). Role of neurogenic inflammation in pancreatitis and pancreatic pain. Neurosignals, 14(4), 158-65.

Bhadada SK, Sahay RK, Jyotsna VP and Agrawal JK. (2001). Diabetic neuropathy: current concepts. Journal Indian Academy of Clinical Medicine, 2(4), 305-18.

Blumenthal M. (2000). Interaction between herbs and conventional drugs. Introductory considerations. Herbalgram, 49, 52-63.

Patel DK, Prasad SK, Kumar R and Hemalatha S. (2012). An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pacific Journal of Tropical Biomedicine, 2(4), 320.

Liu CT, Sheen LY and Lii CK. (2007). Does garlic have a role as an antidiabetic agent? Molecular nutrition and food research, 51(11), 1353-64.

Rohani SM, Moradi M, Mehdizadeh T, Saei-Dehkordi SS and Griffiths MW. (2011). The effect of nisin and garlic (Allium sativum L.) essential oil separately and in combination on the growth of Listeria monocytogenes. LWT-Food Science and Technology, 44(10), 2260-5.

Kumar G, Karthik L and Rao KB. (2011). A review on pharmacological and phytochemical properties of Zingiber officinale Roscoe (Zingiberaceae). Journal of Pharmacy Research, 4(9), 2963-2966.

Rani MP, Krishna MS, Padmakumari KP, Raghu KG and Sundaresan A. (2012). Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, protein glycation and inhibiting adipocyte differentiation: an in vitro study. Journal of the Science of Food and Agriculture, 92(9), 1948-55.

Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R and Ali M. (2006). Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition, 96(4), 660-666.

Ajith TA, Hema U and Aswathy MS. (2007). Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status. Food and Chemical Toxicology, 45(11), 2267-72.

Akram M, Shahab-Uddin AA, Usmanghani K, Hannan A, Mohiuddin E and Asif M. (2010). Curcuma longa and curcumin: a review article. Romanian Journal of Biology - Plant Biology, 55(2), 65-70.

Miquel J, Bernd A, Sempere JM, Dıaz-Alperi J and Ramırez A. (2002). The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Archives of Gerontology and Geriatrics, 34(1), 37-46.

Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C and Jirawatnotai S. (2012). Curcumin extract for prevention of type 2 diabetes. Diabetes care.

Chainani-Wu N. (2003). Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). The Journal of Alternative and Complementary Medicine, 9(1), 161-168.

Xie JT, Mehendale S and Yuan CS. (2005). Ginseng and diabetes. The American Journal of Chinese Medicine, 33(03), 397-404.

Ng TB and Yeung HW. (1985). Hypoglycemic constituents of Panax ginseng. General Pharmacology, 16(6), 549-52.

Paik DJ and Lee CH. (2015). Review of cases of patient risk associated with ginseng abuse and misuse. Journal of Ginseng Research, 39(2), 89-93.

Srinivasan K. (2006). Fenugreek (Trigonella foenum-graecum): A review of health beneficial physiological effects. Food Reviews International, 22(2), 203-24.

Al‐Habori M and Raman A. (1998). Antidiabetic and hypocholesterolaemic effects of fenugreek. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 12(4), 233-42.

Kassaian N, Azadbakht L, Forghani B and Amini M. (2009). Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. International Journal for Vitamin and Nutrition Research, 79(1), 34-9.

Yoshikawa T, Naito Y and Kondo M. (1999). Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxidants and redox signaling, 1(4), 469-80.

Benalla W, Bellahcen S and Bnouham M. (2010). Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Current Diabetes Reviews, 6(4), 247-54.

Mahadevan S and Park Y. (2008). Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. Journal of Food Science, 73(1), R14-9.

Pandey A and Singh S. (2016). Aloe vera: A systematic review of its industrial and ethno-medicinal efficacy. International Journal of Pharmaceutical Research and Allied Sciences, 5(1).

Joseph B and Raj SJ. (2010). Pharmacognostic and phytochemical properties of Aloe vera Linn an overview. International Journal of Pharmaceutical Sciences Review and Research, 4(2), 106-10.

Bala S, Chugh NA, Bansal SC, Garg ML and Koul A. (2017). Safety evaluation of Aloe vera pulp aqueous extract based on histoarchitectural and biochemical alterations in mice. Indian Journal of Experimental Biology, 55, 568-575.

Miraj S and Kiani S. (2016). A review study of therapeutic effects of Salvia officinalis L‏. Der Pharmacia Lettre, 8(6).

Ghorbani A and Esmaeilizadeh M. (2017). Pharmacological properties of Salvia officinalis and its components. Journal of Traditional and Complementary Medicine, 7(4), 433-40.

Lima CF, Azevedo MF, Araujo R, Fernandes-Ferreira M and Pereira-Wilson C. (2006). Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? British Journal of Nutrition, 96(2), 326-33.

Cortés-Rojas DF, de Souza CR and Oliveira WP. (2014). Clove (Syzygium aromaticum): a precious spice. Asian Pacific journal of tropical biomedicine, 4(2), 90-6.

Gülçin İ, Elmastaş M and Aboul-Enein HY. (2012). Antioxidant activity of clove oil–A powerful antioxidant source. Arabian Journal of Chemistry, 5(4), 489-99.

Adefegha SA, Oboh G, Adefegha OM, Boligon AA and Athayde ML. (2014). Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high‐fat diet/streptozotocin‐induced diabetes rat model. Journal of the Science of Food and Agriculture, 94(13), 2726-37.

Jin S and Cho KH. (2011). Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish. Food and Chemical Toxicology, 49(7), 1521-1529.

Hassani FV, Shirani K and Hosseinzadeh H. (2016). Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review. Naunyn-Schmiedeberg's Archives of Pharmacology, 389(9), 931-49.

Aljamal A, Ibrahim A, Al-Fararjeh MA and Alqadi T. (2012). Effects of rosemary on lipid profile in diabetic rats. African Journal of Plant Science, 6(7).

Vlavcheski F, Naimi, M, Murphy B, Hudlicky T and Tsiani E. (2017). Rosmarinic acid, a rosemary extract polyphenol, increases skeletal muscle cell glucose uptake and activates AMPK. Molecules, 22(10), 1669.

Anadon A, Martinez-Larranaga MR, Martinez MA, Ares I, Garcia-Risco MR, Senorans FJ and Reglero G. (2008). Acute oral safety study of rosemary extracts in rats. Journal of Food Protection, 71(4), 790-795.